Impact Factor
3.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.44
727 total citations
h5-index
34
h5 depth signal
Cited share
53.4%
163 of 305
Total citations
727
Citation footprint
Metric signal
2.21
External metric anchor
Self-citation
0.8%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
9,790
United States
5,410
Italy
1,279
Germany
1,227
Japan
1,047
Citing Fields of Research
Oncology
4,948
Cancer & Development
3,692
Cancer, Autophagy & Apoptosis
2,846
Noncoding RNA
2,359
Immunology
2,209
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
27,090
Articles tracked across the journal lifetime
Indexed publication set
305
163 cited publications
Last 12 months
101
8.4 publications/month
Open access share
65.3%
66 OA publications in the last year
Leading citing country
China
9,790 citing publications
Leading citing field
Oncology
4,948 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 2010-v8n30, 2017; v13, 2022-
v1n1, 2010-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Cancer & Development
Noncoding RNA
Cancer, Autophagy & Apoptosis
Lung Cancer
Immunology
Broad Categories
Neoplasms
Noncoding RNA
Cancer & Development
Cancer, Autophagy & Apoptosis
Lung Cancer
Lymphomas
Immunology
MeSH Descriptors
Oncogenes
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.18632/oncotarget.28922
Open DOI
Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived compounds
04
DOI 10.18632/oncotarget.28918
Open DOI
Are both COVID-19 and COVID-19 vaccines associated with cancer?
05
DOI 10.18632/oncotarget.28917
Open DOI
Re-expression of MHC-I to treat CNS cancers
06
07
DOI 10.18632/oncotarget.28912
Open DOI
Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine
08
09
DOI 10.18632/oncotarget.28911
Open DOI
Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers
10
DOI 10.18632/oncotarget.28899
Open DOI
WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers
Bibliographical & Catalog Notes
"Open access impact journal."